A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study
ConclusionsThe AEFI reported with COVID-19 vaccines in Lebanon were aligned with those reported worldwide. The incidence of rare serious AEFIs should not discourage the public from getting vaccinated. Further studies are needed to evaluate their long-term potential risk.
Source: Journal of Pharmaceutical Policy and Practice - Category: Pharmaceuticals Source Type: research
More News: AstraZeneca | Coronavirus | Covid Vaccine | COVID-19 | Lebanon Health | Middle East Health | Pain | Pfizer | Pharmaceuticals | Study | Vaccines